New scan could reveal within days if brain tumor treatment is working
NCT ID NCT02902757
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested whether a type of PET/CT scan (FDG PET/CT) can detect very early changes in glioblastoma tumors after starting chemotherapy. Seven patients with high-grade glioma were scanned shortly after beginning therapy to see if changes in glucose uptake could predict later response. The goal was to find a way to quickly tell if treatment is working, potentially allowing doctors to adjust therapy sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fludeoxyglucose F-18 (FDG)
What this could lead to
If successful, this imaging method could help doctors quickly see if a glioblastoma treatment is working, allowing earlier adjustments.
What could go wrong
This was a very small pilot study with only 7 participants, so results may not apply to all patients. The technique is still experimental and not yet proven to improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States